Topline Phase 3 TRIUMPH-1 trial results show retatrutide drives a 30.3 percent body weight loss over 104 weeks of treatment.

Earlier this week, Definium Therapeutics reported that its Phase 3 Emerge trial of DT120 ODT in major depressive disorder met its primary and all key secondary endpoints, showing rapid and durable ...

The company reported that the U.S. Food and Drug Administration aligned with the company on several key aspects of the Phase ...

Monopar Therapeutics Inc. ('Monopar” or the 'Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today ...

Authorities have identified hundreds of violations following a court-directed survey of nearly 5,100 properties ...

Galectin Therapeutics is a Buy as recent FDA alignment de-risks belapectin’s Phase 3 path and clarifies regulatory endpoints.

C-FORWARD and C-BEYOND Represent the First Global Phase 3 Head-to-Head Trials of Direct-Acting Antivirals for the Treatment of HCV BOSTON, June 25, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc.

The league completes its third phase of expansion, in which each of the eight existing teams protects three additional players.

Brepocitinib is a first-in-class, oral, selective TYK2–JAK1 inhibitor that blocks cytokine signaling, which has been implicated in dermatomyositis. In this phase 3, double-blind, randomized, ...